Metabolomic Diagnostics is a biotech startup that was founded in 2011. Specializing in Big Data, Biotechnology, and Health Care, the company has garnered attention for its innovative approach to metabolomic testing. Their most recent investment was a Seed Round investment on 21 December 2022, with the funding coming from SOSV, a prominent venture capital firm. Metabolomic Diagnostics' technology has the potential to revolutionize the field of health care by providing personalized and accurate diagnostic solutions.
Metabolomic Diagnostics
Improving Pregnancy Outcomes Globally
Founded 2011
Ireland
12 employees
Seed
Total: $7.93M
Big Data, Biotechnology +3
Ireland
12 employees
Seed
Total: $7.93M
Big Data, Biotechnology +3
General Information
Company Name
Metabolomic Diagnostics
Founded Year
2011
Location
Ireland
Ireland
Employees
12
Industries
Big Data, Biotechnology, Health Care +2
Funding Stage
Seed
BounceWatch is an independent company data service, not affiliated with Metabolomic Diagnostics. To contact Metabolomic Diagnostics, visit metabolomicdiagnostics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Metabolomic Diagnostics compare?
A PDF of Metabolomic Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Metabolomic Diagnostics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Ireland Market
Big Data
About Metabolomic Diagnostics
Funding Rounds & Investors (12)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | Undisclosed | 1 |
|
21 Dec 2022 |
| Convertible Note | Undisclosed | 1 |
|
19 Apr 2022 |
| Grant | €200.00K | 1 |
|
01 Jul 2020 |
| Convertible Note | €500.00K | 4 |
|
28 Apr 2020 |
| Grant | €2.00M | 1 |
|
16 May 2018 |
| Venture Round | €1.00M | 4 |
|
06 Apr 2018 |
| Venture Round | €1.66M | 5 |
|
16 Jun 2016 |
| Venture Round | €125.00K | 1 |
|
30 Jan 2015 |
| Venture Round | €625.00K | 2 |
|
08 Dec 2014 |
| Seed Round | €750.00K | 3 |
|
20 Dec 2013 |
Metabolomic Diagnostics Alternatives & Competitors
Metabolomic Diagnostics vs
Sera Prognostics
United States
The Pregnancy Company
Series E
72 employees
Biotechnology, Health Care
FAQ About Metabolomic Diagnostics
Improving Pregnancy Outcomes Globally
Metabolomic Diagnostics was founded in 2011.
Metabolomic Diagnostics is headquartered in Ireland.
Metabolomic Diagnostics operates in Big Data, Biotechnology, Health Care, Life Sciences and Clean Energy.
Metabolomic Diagnostics has approximately 12 employees.
Metabolomic Diagnostics has completed 12 funding rounds, raising a total of $7.93M. The latest funding stage is Seed.
Top alternatives and competitors to Metabolomic Diagnostics include Sera Prognostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Metabolomic Diagnostics and Sera Prognostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Metabolomic Diagnostics, https://bouncewatch.com/company/metabolomic-diagnostics, updated 30 December 2024. When citing, please name BounceWatch and link this page.
